An International, Multi-Institutional Trial of DCE-MRI in Children Treated for Osteosarcoma

Apparent Diffusion Coefficients Show Good Reproducibility But Heterogeneous Change in Response to Treatment with Combrestation A4 Phosphate (CA4P) and Bevacizumab in Patients with Solid Abdominal and Pelvic Tumours

DCE-MRI Demonstration of Antivascular Effects of Combretastatin A4 Phosphate (CA4P) Given in Combination with Bevacizumab to Human Subjects with Advanced Solid Tumours

Dynamic Contrast Enhanced MRI as a Predictor of Long Term Outcome in Pediatric Bone Tumors

Dynamic Contrast Enhanced MRI of Solid Tumors and Healthy Tissue During Treatment with NGR-TNF, a Novel Vascular Targeting Agent